Filtros de búsqueda

Lista de obras de Luca Paoluzzi

BET and BRAF inhibitors act synergistically against BRAF-mutant melanoma

artículo científico publicado en 2016

Bortezomib-induced tumor lysis syndrome in a patient with HIV-negative plasmablastic lymphoma

artículo científico publicado en 2010

Development and characterization of a novel CD19CherryLuciferase (CD19CL) transgenic mouse for the preclinical study of B-cell lymphomas

artículo científico publicado en 2012

Diagnosis, Prognosis, and Treatment of Alveolar Soft-Part Sarcoma: A Review

article

Extraskeletal myxoid chondrosarcoma with massive pulmonary metastases

Hepatic arterial continuous infusion (HACI) of oxaliplatin in patients with unresectable liver metastases from colorectal cancer.

artículo científico publicado en 2003

Influence of genetic variants in UGT1A1 and UGT1A9 on the in vivo glucuronidation of SN-38.

artículo científico publicado en 2004

New drugs for the treatment of lymphoma

artículo científico publicado en 2008

Pralatrexate is synergistic with the proteasome inhibitor bortezomib in in vitro and in vivo models of T-cell lymphoid malignancies

artículo científico publicado en 2010

Regenerating articular tissue by converging technologies

artículo científico publicado en 2008

Response to anti-PD1 therapy with nivolumab in metastatic sarcomas.

artículo científico publicado en 2016

Romidepsin and belinostat synergize the antineoplastic effect of bortezomib in mantle cell lymphoma

artículo científico publicado en 2010

Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma

artículo científico publicado en 2008

Targeting survival pathways in lymphoma

artículo científico publicado el 1 de enero de 2010

The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies

artículo científico publicado en 2008

The anti-histaminic cyproheptadine synergizes the antineoplastic activity of bortezomib in mantle cell lymphoma through its effects as a histone deacetylase inhibitor.

artículo científico publicado en 2009

The novel kinesin spindle protein (KSP) inhibitor SB-743921 exhibits marked activity in in vivo and in vitro models of aggressive large B-cell lymphoma

artículo científico publicado en 2015

Weekly paclitaxel and 5-fluorouracil in pretreated patients with metastatic breast cancer: a phase I study.

artículo científico publicado en 2003